Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464654

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464654

Bioprocess validation Market, By Test Type, By Process Component, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

PUBLISHED:
PAGES: 260 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Bioprocess validation Market size was valued at USD 420.91 Million in 2023, expanding at a CAGR of 9.83% from 2024 to 2032.

Bioprocess validation plays a vital role in guaranteeing the safety, quality, and effectiveness of bioproducts, including vaccines, antibodies, enzymes, and biosensors. Its purpose is to demonstrate that a bioprocess can consistently generate the desired bioproduct according to predetermined specifications and conditions. In the pharmaceutical industry, bioprocess validation is a mandatory regulatory requirement that ensures the uniformity and excellence of biopharmaceutical products throughout their entire lifespan.

Bioprocess validation Market- Market Dynamics

Surge in demand for outsourcing bioprocess validation and increase in life science R&D expenditure are expected to drive the market growth.

Numerous pharmaceutical and biotechnology companies are increasingly delegating various aspects of their operations, such as bioprocess validation. With the expansion of R&D activities in the life sciences sector, there is a rising demand for services related to bioprocess validation to facilitate the development and production of new biopharmaceutical products. Global expenditure on R&D has surged to nearly US$ 1.7 trillion, with approximately 10 countries contributing to 80% of the spending. As part of the Sustainable Development Goals (SDGs), nations have committed to significantly boosting public and private R&D expenditure, as well as the number of researchers, by 2030, as per the UNESCO Institute for Statistics (UIS). Additionally, advancements in bioprocessing technologies and regulatory compliance requirements may present growth opportunities for the market. Nonetheless, the high cost of validation could impede market growth.

Bioprocess validation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.83% over the forecast period (2024-2032)

Based on Test Type segmentation, Extractables & Leachables Testing was predicted to show maximum market share in the year 2023

Based on Process Component segmentation, Filter Elements was the leading type in 2023

Based on End-User segmentation, Pharmaceutical & Biotechnology Companies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioprocess validation Market- Segmentation Analysis:

The Global Bioprocess validation Market is segmented on the basis of Test Type, Process Component, End-User, and Region.

The market is categorized into four groups according to the Test Type: Extractables & Leachables Testing, Bioprocess Residuals Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. The dominant category in the market is Extractables & Leachables Testing. This type of testing plays a crucial role in the development and manufacturing of pharmaceutical products, especially when it comes to packaging materials, containers, and processing equipment used in biopharmaceutical production.

The market is segmented into five categories according to Process Component: Filter Elements, Media containers and bags, Freezing And Thawing Process Bags, Mixing Systems, Bioreactors, Transfer Systems and Others. Filter Elements are the leading category in the market. They play a vital role in biopharmaceutical manufacturing processes, especially in downstream processing.

The market is segmented into three groups according to the end-users: Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations, and Other. The dominant force in the market is the Pharmaceutical & Biotechnology Companies. These companies play a significant role in driving the demand for bioprocess validation services. Given their involvement in the development and production of biopharmaceutical products, it is crucial for them to maintain consistent quality and adhere to regulatory standards in their manufacturing processes.

Bioprocess validation Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is anticipated to be primarily driven by North America, particularly the United States, owing to the rising demand for Biopharmaceuticals. The United States boasts a strong and well-established biopharmaceutical industry. Validation of bioprocesses plays a critical role in ensuring the quality, safety, and effectiveness of biopharmaceutical products, leading to an increased demand for validation services and products. As per Pharmaceutical Statistics, the U.S. pharmaceutical industry recorded a revenue of $550 billion in 2021, while Americans spent USD 576.9 billion on medications. Europe stands as the second-largest region for market growth.

Bioprocess validation Market- Competitive Landscape:

The bioprocess validation market is experiencing substantial growth as a result of the rising need for biopharmaceuticals, advancements in bioprocess technology, and strict regulatory standards. Manufactures in this market are constantly striving to innovate and create cutting-edge technologies and methodologies for validating bioprocesses. By staying at the forefront of innovation, these companies gain a competitive advantage by providing validation solutions that are more efficient, accurate, and cost-effective. Additionally, companies that prioritize customer satisfaction and establish strong consumer relationships often benefit from repeat business and transfers, further enhancing their competitive position.

Recent Developments:

Eurofins BioPharma Product Testing Columbia part of the biggest network of harmonized bio/pharmaceutical GMP product testing facilities globally, announced a collaboration agreement with Plus Therapeutics, Inc. ("Plus Therapeutics"), a clinical stage pharmaceutical company developing novel, targeted therapies for rare and difficult cancers.

April 30, 2020, Merck, a leading science and technology company, today unveiled the next component of its BioContinuum Platform, the Bio4C Software Suite, generating a first-of-its-kind ecosystem that syndicates process control, analytics as well as plant-level automation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROCESS VALIDATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Eurofins Scientific, Inc.

Sartorius AG

Merck KGaA

Thermo Fisher Scientific Inc.

Lonza

Danaher Corporation

Charles River Laboratories

SGS S.A.

Toxikon Corporation

Cobetter Filtration Equipment Co., Ltd.

Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Extractables & Leachables Testing
  • Bioprocess Residuals Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY PROCESS COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Filter Elements
  • Media containers and bags
  • Freezing And Thawing Process Bags
  • Mixing Systems
  • Bioreactors
  • Transfer Systems
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organizations
  • Other

GLOBAL BIOPROCESS VALIDATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV2456

Table of Contents

1.Bioprocess Validation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Bioprocess Validation Market Snippet by Test Type
    • 2.1.2.Bioprocess Validation Market Snippet by Process Component
    • 2.1.3.Bioprocess Validation Market Snippet by End-User
    • 2.1.4.Bioprocess Validation Market Snippet by Country
    • 2.1.5.Bioprocess Validation Market Snippet by Region
  • 2.2.Competitive Insights

3.Bioprocess Validation Key Market Trends

  • 3.1.Bioprocess Validation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Bioprocess Validation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Bioprocess Validation Market Opportunities
  • 3.4.Bioprocess Validation Market Future Trends

4.Bioprocess Validation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Bioprocess Validation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Bioprocess Validation Market Landscape

  • 6.1.Bioprocess Validation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Bioprocess Validation Market - By Test Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2.Extractables & Leachables Testing
    • 7.1.3.Bioprocess Residuals Testing
    • 7.1.4.Viral Clearance Testing
    • 7.1.5.Filtration & Fermentation Systems Testing
    • 7.1.6.Others

8.Bioprocess Validation Market - By Process Component

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Process Component, 2023 & 2032 (%)
    • 8.1.2.Filter Elements
    • 8.1.3.Media containers and bags
    • 8.1.4.Freezing And Thawing Process Bags
    • 8.1.5.Mixing Systems
    • 8.1.6.Bioreactors
    • 8.1.7.Transfer Systems
    • 8.1.8.Others

9.Bioprocess Validation Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical & Biotechnology Companies
    • 9.1.3.Contract Development & Manufacturing Organizations
    • 9.1.4.Other

10.Bioprocess Validation Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Bioprocess Validation Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Bioprocess Validation Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Bioprocess Validation Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Bioprocess Validation Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Bioprocess Validation Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Bioprocess Validation Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Eurofins Scientific, Inc.
    • 11.2.2.Sartorius AG
    • 11.2.3.Merck KGaA
    • 11.2.4.Thermo Fisher Scientific Inc.
    • 11.2.5.Lonza
    • 11.2.6.Danaher Corporation
    • 11.2.7.Charles River Laboratories
    • 11.2.8.SGS S.A.
    • 11.2.9.Toxikon Corporation
    • 11.2.10.Cobetter Filtration Equipment Co., Ltd.
    • 11.2.11.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us
Product Code: ANV2456

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bioprocess Validation Market: Test Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Bioprocess Validation Market, by Test Type 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Process Component Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Process Component
  • TABLE Global Bioprocess Validation Market, by Process Component 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Bioprocess Validation Market, by End-User 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bioprocess Validation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!